Published:
Category: Group updates
ID.me identity verification system to access CTEP CTSU websites

To ensure the security and safety of National Cancer Institute (NCI) systems, subjects, research staff, and all associated sensitive information, NCI introduced Identity Proofing (IP) and Multi-Factor Authentication (MFA) in accordance with the Federal Information Security Management Act (FISMA) in July of this year. This is applicable to all accessing the systems, including Canadians.

Read More

Published:
Category: News

September is Prostate Cancer Awareness Month and in 2020, 23,300 Canadian men were diagnosed with prostate cancer of which one third are estimated to have unfavourable risk, non-metastatic prostate cancer.

This story was published by Sunnybrooke Health Sciences Centre

Read More

Published:
Category: Office of the Director
Office of the Director - Fall 2022 Group Update

From the Director’s Desk

September still feels like the beginning of a new year to me.

Read More

Published:
Category: Publications

CO28: NEOadjuvant Chemotherapy, Excision and Observation for Early Rectal Cancer: The NEO Trial

Recently published in the Journal of Clinical Oncology

Read More

Published:
Category: Publications
Long-Term ADT with Radiation Helps Prevent Post-Prostatectomy Metastases

First results from the CCTG PR13 RADICALS: Radiotherapy and Androgen Deprivation In Combination After Local Surgery were presented at the European Society for Medical Oncology (ESMO) 2022 annual congress in Paris France on September 12.

Read More



Published:
Category: Group updates
Welcome to new Patient Representative Hilary Horlock

Hilary Horlock is a Senior Enterprise Architect. She specializes in healthcare technology design from an end user perspective. Implementing technology successfully in complex health care ecosystems often comprised of large personalities and competing demands takes expert navigation skills, liberal doses of good humor, a keen sense of observation and refreshing honesty.

Read More

Published:
Category: Publications

The CO26 sub-study: Circulating Tumor DNA Identifies Diverse Landscape of Acquired Resistance to Anti-Epidermal Growth Factor Receptor Therapy in Metastatic Colorectal Cancer has recently been published in Journal of Clinical Oncology.

Read More

Published:
Category: Publications
Six-Year Results From RELEVANCE: Lenalidomide Plus Rituximab (R2) Versus Rituximab-Chemotherapy Followed by Rituximab Maintenance in Untreated Advanced Follicular Lymphoma
 
Morschhauser F, Nastoupil L, Feugier P, Schiano de Colella J-M, Tilly H, Palomba ML, Bachy E, Fruchart C, Libby EN, Casasnovas RO, Flinn IW, Haioun C, Maisonneuve H, Ysebaert L, Bartlett NL, Bouabdallah K, Brice P, Ribrag V, Le Gouill S, Daguindau N, Guidez S, Pica GM, García-Sancho AM, López-Guillermo A, Larouche JF, Ando K, Gomes da Silva M, André M, Kalung W, Sehn LH, Izutsu K, Cartron G, Gk
Read More